How do you treat leptomeningeal disease in metastatic HR+ HER2- breast cancer?

Survival after a diagnosis of leptomeningeal metastasis (LM) remains poor. Radiation therapy remains a primary therapy for breast cancer LM. Intrathecal therapy has resulted in limited efficacy and is associated with significant toxicity. Limited data regarding the efficacy of systemic therapies in ...